==== Front New Microbes New InfectNew Microbes New InfectNew Microbes and New Infections2052-2975Elsevier S2052-2975(18)30058-110.1016/j.nmni.2018.07.002Letter to the EditorGenomics helps to decipher the resistance mechanisms present in a Pseudomonas chlororaphis strain recovered in an HIV patient Montaña S. 1Lazzaro T. 2Uong S. 2Place K. 2Iriarte A. 3Ocampo C.V. 4Vay C. 45Ramírez M.S. msramirez@fullerton.edu2∗1) Instituto de Microbiología y Parasitología Médica (IMPaM, UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina2) Centre for Applied Biotechnology Studies, Department of Biological Science, California State University Fullerton, Fullerton, CA, USA3) Dpto de Desarrollo Biotecnológico, Instituto de Higiene, Facultad de Medicina, UdelaR, Montevideo, Uruguay4) Sanatorio Mater Dei, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina5 Laboratorio de Bacteriología, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina∗ Corresponding author: M.S. Ramírez, Department of Biological Science, California State University Fullerton, Fullerton, CA, USA. msramirez@fullerton.edu09 7 2018 9 2018 09 7 2018 25 45 47 4 4 2018 26 6 2018 4 7 2018 © 2018 The Author(s)2018This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords Carbapenem-resistanceHIV PatientMetallo-β-lactamasephnPPseudomonas chlororaphis ==== Body To the Editor The genus Pseudomonas is one of the most diverse and ubiquitous bacterial genera, encompassing more than 140 isolated species [1], [2]. The species Pseudomonas chlororaphis is primarily used as an agricultural biocontrol because of its unique ability to inhibit the growth of soil-borne pathogens and produce phenazine-1-carboxamide—an antifungal metabolite [3], [4], [5], [6]. A literature review of the species revealed the presence of 28 genome assemblies of P. chlororaphis, among which, seven were complete genomes. To the best of our knowledge, there has only been one reported case in a human of pathogenic P. chlororaphis [7]. Here we aim to describe the occurrence of two P. chlororaphis isolates recovered from an individual with human immunodeficiency virus infection and to characterize the isolate at a molecular level. Our findings, along with the previous reports, demonstrate the ability of this species to serve as a reservoir for resistance determinants and serve as a human pathogen. Two P. chlororaphis isolates (PC190 and PC477) were recovered from the respiratory tract and anal mucous sample of a 63-year-old man. The patient presented with aspirate pneumonia and is AIDS positive, receiving highly active antiretroviral therapy. In February of 2013, the patient was on an R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) regimen—a treatment for aggressive non-Hodgkin lymphoma, diffuse large B-cell lymphoma. After 5 months of treatment, the patient was in remission with intermittent leukopenia. In October of 2013, he was admitted with a urinary infection due to Pseudomonas aeruginosa. He received broad-spectrum antibiotic treatment with imipenem and ciprofloxacin. One month later, the patient presented with a chief complaint of fever (38.5°C) and a cough. A pulmonary infiltrate from the apical segment of the right lower lobe was taken. No bacterial development was observed and he received an empirical treatment with imipenem, colistin and vancomycin. During this period, he also presented with an episode of hypotension, distal coldness, filiform pulse and profuse sweating. A computed tomography scan of the chest revealed the progression of a bilateral pulmonary infiltrate. This prompted the clinicians to take a tracheobronchial aspirate biopsy. Following standard procedure, this was screened for carbapenem-resistant Enterobacteriaceae. The tracheobronchial aspirate culture showed the development of Klebsiella pneumoniae and P. chlororaphis, and the anal swab showed a P. chlororaphis infection. As the patient improved with the administration of corticosteroids, it was interpreted as suprarenal insufficiency. The strains were identified at species level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonics, Bremen, Germany), gyrB amplification, and sequencing. MALDI-TOF MS identified the strain as P. chlororaphis with a score of >2. These results were confirmed with the gyrB, rpoB and 16S rDNA sequence analysis. The analysis revealed a 99% identity to P. chlororaphis Lzh-T5 (AN CP025309), 99% identity with P. chlororaphis PA23 (AN CP008696) and a 100% identity with P. chlororaphis PA23, respectively, for each gene. Antimicrobial susceptibility testing was performed using VITEK 2 (bioMérieux, Marcy l’Etoile, France) and the results were interpreted in accordance with the CLSI 2017 standard (Table 1). These strains exhibited resistance to different β-lactam antibiotics, including carbapenems. degenerate oligonucleotide primers (DO-PCR)/OD confirmed the genetic relationship between the isolates (data not shown).Table 1 Minimum inhibitory concentrations of antimicrobial agents in PC190 and PC477 isolates pf Pseudomonas chlororaphis Table 1Isolate MIC (mg/L) AMP AMS CEP CTX CAZ FEP TAZ IMP MEM AMK GEN CIP COL TMS PC190 ≥32 (R) ≥32 (R) ≥64 (R) ≥64 (R) 16 (I) 2 (I) 32 (I) ≥16 (R) ≥16 (R) ≤2 (S) ≤1 (S) ≤0.25 (S) ≤0.5 (S) 80 (R) PC477 ≥32 (R) ≥32 (R) ≥64 (R) ≥64 (R) 16 (I) 2 (I) 32 (I) ≥16 (R) ≥16 (R) ≤2 (S) ≤1 (S) ≤0.25 (S) ≤0.5 (S) 80 (R) Abbreviations: AMP, ampicillin; AMS, ampicillin-sulbactam; CEP, cephalothin; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; TAZ, piperacillin-tazobactam; IMP, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; CIP, ciprofloxacin; COL, colistin; TMS, trimethoprim/sulfamethoxazole. Metallo-β-lactamase (MBL) activity was confirmed by synergism between carbapenems and EDTA using a double-disc assay with EDTA/sodium mercaptoacetic acid (SMA) discs (1900 g/750 g per disc, respectively; Laboratorios Britania, Buenos Aires, Argentina) placed 15 mm (centre to centre) from a carbapenem disc (imipenem and meropenem). An ‘egg-shaped effect’ was observed in the zone of inhibition of a carbapenem-containing disc with the zinc chelating agent (EDTA) disc; these results potentially exposed the presence of MBLs. To further explore the genetic contents, one isolate (PC190) was selected for whole genome sequencing. The draft genome sequence was obtained with Illumina MiSeq-I and Nextera XT DNA library. De novo assembly was performed with SPADES assembler 3.1.0 version [8]. RAST was used to predict the open reading frames and the predictions were confirmed using BLAST (version 2.0) [9]. Further genomic analysis was carried out using ARG-ANNOT [10], ISFinder [11] and PHAST [12]. The draft genome of PC190 comprises 6 791 658 bp. The RAST server predicted 6052 protein-coding genes with a corresponding G+C content of 63.0%. The genome analysis of PC190 exposed the presence of a β-lactamase gene, ampC, and two copies of an MBL, phnP. The latter gene was flanked by a gene coding for phosphoribosylaminoimidazole-succinocarboxamide synthase downstream and a hypothetical protein upstream, and this was followed by a gene coding for dihydrodipicolinate synthase (Fig. 1). Several efflux pumps such as CmeABC, MexCD-OprJ and MexEF-OprN, were also found. Among resistance genes in PC190, a fosfomycin-resistance protein flanked by LysE, coding for a lysine transporter, was found downstream. A hypothetical protein upstream and streptothricin-resistance protein flanked upstream by a transcriptional regulator (LysR) downstream and upstream by a lysine decarboxylase protein. No insertion sequences were found. Using PHAST software, two intact and two incomplete phages were found.Fig. 1 Genetic environment of phnP found in Pseudomonas chlororaphis PC190 genome. The genes are shown by grey arrow boxes indicating the transcriptional orientation. HP, hypothetical protein. Fig. 1 Recent reports of emerging pathogens that have acquired exogenous DNA from other bacterial species, and/or serve as reservoir of resistance genes are more common than was previously thought. The variety of resistance genes found in the PC190 genome can explain the multidrug-resistance phenotype. We also demonstrate the importance of the uncommon multidrug-resistance pathogens isolated from clinical specimens. Acknowledgements SM has a Doctoral Fellowship from CONICET. This work was supported by grants from the ‘Secretaría de Ciencia y Técnica de la Universidad de Buenos Aires’ (UBACyT) to CV and MSR, Buenos Aires, Argentina. ==== Refs References 1 Peix A. Ramírez-Bahena M.H. Velázquez E. The current status on the taxonomy of Pseudomonas revisited: an update Infect Genet Evol 57 2017 106 116 29104095 2 Anzai Y. Kim H. Park J.Y. Wakabayashi H. Oyaizu H. Phylogenetic affiliation of the Pseudomonas based on 16S rRNA sequence Int J Syst Evol Microbiol 50 2000 1563 1589 10939664 3 Shen X. Chen M. Hu H. Wang W. Peng H. Xu P. Genome sequence of Pseudomonas chlororaphis GP72, a root-colonizing biocontrol strain J Bacteriol 194 2012 1269 1270 22328763 4 Vida C. de Vicente A. Cazorla F.M. Draft genome sequence of the rhizobacterium Pseudomonas chlororaphis PCL1601, displaying biocontrol against soilborne phytopathogens Genome Announc 5 2017 pii:e00130-17 5 Thomas F.C. Woeng C. Bloeberg G. Mulders I. Dekkers L. Lugtenberg B. Root colonization by phenazine-1-carboxamide-producing bacterium Pseudomonas chlororaphis PCL1391 is essential for biocontrol of tomato foot and root rot Am Phytopathol Soc 13 2000 1340 1345 6 Yu J.M. Wang D. Ries T.R. Pierson L.S. III Pierson E.A. An upstream sequence modulates phenazine production at the level of transcription and translation in the biological control strain Pseudomonas chlororaphis 30-84 PLoS One 13 2018 e0193063 29451920 7 Faccone D. Pasteran F. Albornoz E. Gonzalez L. Veliz O. Prieto M. Human infections due to Pseudomonas chlororaphis and Pseudomonas oleovorans harboring new bla(VIM-2)-borne integrons Infect Genet Evol 28 2014 276 277 25460821 8 Bankevich A. Nurk S. Antipov D. Gurevich A.A. Dvorkin M. Kulikov A.S. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing J Comput Biol 19 2012 455 477 22506599 9 Aziz R.K. Bartels D. Best A.A. DeJongh M. Disz T. Edwards R.A. The RAST server: rapid annotations using subsystems technology BMC Genomics 9 2008 75 18261238 10 Gupta S.K. Padmanabhan B.R. Diene S.M. Lopez-Rojas R. Kempf M. Landraud L. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes Antimicrob Agents Chemother 58 2014 212 220 24145532 11 Siguier P. Perochon J. Lestrade L. Mahillon J. Chandler M. ISfinder: the reference centre for bacterial insertion sequences Nucleic Acids Res 34 2006 D32 D36 16381877 12 Zhou Y. Liang Y. Lynch K.H. Dennis J.J. Wishart D.S. PHAST: a fast phage search tool Nucleic Acids Res 39 2011 W347 W352 21672955